FY2017 EPS Estimates for Stericycle Inc. Cut by Barrington Research (SRCL)
Stericycle Inc. (NASDAQ:SRCL) – Equities researchers at Barrington Research dropped their FY2017 EPS estimates for shares of Stericycle in a note issued to investors on Wednesday. Barrington Research analyst K. Steinke now expects that the firm will post earnings of $4.79 per share for the year, down from their previous forecast of $5.10. Barrington Research has a “Outperform” rating and a $88.00 price target on the stock.
A number of other equities analysts also recently weighed in on the stock. Jefferies Group restated a “buy” rating and set a $112.50 target price (down from $125.00) on shares of Stericycle in a report on Wednesday, September 7th. Zacks Investment Research upgraded shares of Stericycle from a “hold” rating to a “buy” rating and set a $117.00 target price on the stock in a report on Monday, July 11th. Wellington Shields downgraded shares of Stericycle from an “accumulate” rating to a “hold” rating in a report on Friday, July 29th. Finally, Macquarie began coverage on shares of Stericycle in a report on Thursday, August 25th. They set a “neutral” rating and a $96.00 target price on the stock. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the company. Stericycle currently has an average rating of “Hold” and an average target price of $103.54.
Shares of Stericycle (NASDAQ:SRCL) traded down 1.70% during trading on Friday, hitting $75.10. 1,574,872 shares of the stock were exchanged. Stericycle has a 1-year low of $74.95 and a 1-year high of $151.57. The firm’s 50-day moving average is $81.55 and its 200 day moving average is $99.23. The company has a market cap of $6.39 billion, a P/E ratio of 26.43 and a beta of 0.20.
Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.18. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. The company earned $891.60 million during the quarter, compared to analysts’ expectations of $910.29 million. During the same quarter in the prior year, the company posted $1.14 EPS. The business’s revenue was up 24.6% on a year-over-year basis.
Large investors have recently added to or reduced their stakes in the stock. Balentine LLC raised its stake in Stericycle by 15.0% in the second quarter. Balentine LLC now owns 1,224 shares of the company’s stock valued at $127,000 after buying an additional 160 shares in the last quarter. Pinkerton Retirement Specialists LLC bought a new stake in Stericycle during the second quarter valued at approximately $131,000. Parkside Financial Bank & Trust increased its stake in Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock valued at $149,000 after buying an additional 41 shares during the period. Meeder Asset Management Inc. bought a new stake in Stericycle during the second quarter valued at approximately $155,000. Finally, Canada Pension Plan Investment Board increased its stake in Stericycle by 54.1% in the first quarter. Canada Pension Plan Investment Board now owns 1,415 shares of the company’s stock valued at $179,000 after buying an additional 497 shares during the period. Institutional investors own 92.80% of the company’s stock.
In related news, EVP John P. Schetz sold 1,398 shares of Stericycle stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total transaction of $114,426.30. Following the sale, the executive vice president now directly owns 1,088 shares in the company, valued at $89,052.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Rodney F. Dammeyer sold 10,188 shares of Stericycle stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $85.50, for a total value of $871,074.00. Following the sale, the director now owns 10,188 shares in the company, valued at $871,074. The disclosure for this sale can be found here. Insiders own 3.30% of the company’s stock.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.